In the Hatch-Waxman arena of patent litigation, the crisscross of patent laws and FDA regulations is always in play. In the recent Federal Circuit decision in Jazz Pharmaceuticals, Inc. v. Avadel CNS ...

Before Moore, Schall, and Taranto. Appeal from the Patent Trial and Appeal Board. Summary: The Board erred by finding method-claim steps connected by “and” to be conditional and by never explaining ...

“The insurance claim may comprise any of a claim against one or more of a health insurance, a worker compensation insurance, a liability insurance, a homeowner’s insurance, a property casualty ...

The method of claim 1, wherein the physical token is an identification card. “5. The method of claim 1, wherein the physical token is a state issued driver’s license. “6. The computer implemented ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

Molecular biomarkers, such as variations in genetic sequences, protein levels, or combinations of specific biochemical changes, are increasingly important to the emergence of personalized medicine.

During the rapid development of the biotech industry in the nineties, large numbers of tests, research tools and assays were developed. Such inventions were primarily patent-protected using "method" ...